Unnamed corporates have provided capital for Panlin’s $148m fund that will focus on healthcare, digital transformation and smart hardware.
China-based venture capital firm Panlin Capital has closed a RMB1bn ($148m) fund with limited partners including unnamed corporates, government guidance funds, funds of funds and individual backers, China Money Network reported yesterday.
Founded in 2010, Panlin Capital has so far launched a total of 10 funds focused on various industries.
The latest vehicle will focus on drug developers targeting major diseases, medical device manufacturers and digital transformation services providers as well as smart consumer hardware producers.
Panlin did not specify…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
